SpaceX Plans Starship Tests for In-Orbit Drug Research

NASA's SpaceX Crew-11 mission aboard the International Space Station will conduct significant scientific research, including studying plant cell division, microgravity's effects on viruses, and producing larger volumes of human stem cells. The StemCellEx-IP1 experiment aims to use microgravity to generate 1,000 times more induced pluripotent stem cells than on Earth, potentially advancing regenerative medicine treatments. SpaceX is also developing a commercial program using its Starship rocket to manufacture products, including drug research, in space, which could open new business opportunities for the company. Despite recent technical challenges such as a nitrogen tank explosion destroying an upper stage, SpaceX has successfully landed and reused the Super Heavy booster on previous flights. Upcoming SpaceX launches from Vandenberg include a first-stage booster landing on a droneship in the Pacific Ocean, with some sonic boom effects possible in California counties. Live webcast and viewing opportunities are provided for these launches, underscoring SpaceX's ongoing commitment to both space exploration and commercial spaceflight innovation.